What specific directions should be provided when prescribing super-, high-, and midpotency topical steroids? Education is imperative. Side effects should be discussed, as well as correct application methods to avoid misuse. Failure to do so may result in nonadherence and irrational steroid phobia. Timely follow-up should be scheduled to monitor for treatment and side effects. The directions should specify that the potent topical steroid should not be used in areas of thin skin (e.g., face, neck), and in intertriginous locations where skin touches skin (e.g., axilla, inframammary, infrapannus, groin). Areas of thinner epidermis provide less resistance and facilitate absorption. In addition, apposition of two skin surfaces simulates an occlusive dressing, which greatly enhances penetration and absorption of medication. Because it is common for patients to distribute their medication to other family members or friends, or save it for use on another skin problem in the future, instructions should include exclusive use by the patient only and for this particular rash only. Charman CR, Morris AD, Williams HC: Topical corticosteroid phobia in patients with atopic eczema, Br J Dermatol 142(5):931–936, 2000. |
© 2024 Skin Disease & Care | All Rights Reserved.